Terms: = Prostate cancer AND MUC16, CA125, CA-125 AND Diagnosis
63 results:
1. Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers.
Gronnier M; Hedhli K; Sauzay C; Salle V; Duhaut P; Schmidt J; Dernoncourt A
BMC Cancer; 2024 Apr; 24(1):468. PubMed ID: 38622530
[TBL] [Abstract] [Full Text] [Related]
2. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
3. Tumour Marker Requisition Pattern in a Tertiary Care Centre of Eastern Nepal.
Niraula A; Gelal B; Chaudhari RK; Das BK; Lamsal M
Kathmandu Univ Med J (KUMJ); 2022; 20(80):422-426. PubMed ID: 37795716
[TBL] [Abstract] [Full Text] [Related]
4. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
[TBL] [Abstract] [Full Text] [Related]
5. Flexible diagnostic measures and new cut-point selection methods under multiple ordered classes.
Feng Y; Tian L
Pharm Stat; 2022 Jan; 21(1):220-240. PubMed ID: 34449107
[TBL] [Abstract] [Full Text] [Related]
6. Nanotechnology in ovarian cancer: diagnosis and treatment.
Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
[TBL] [Abstract] [Full Text] [Related]
7. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
[TBL] [Abstract] [Full Text] [Related]
8. A case of primary adenocarcinoma of the seminal vesicle treated by total laparoscopic pelvic exenteration.
Tochigi K; Matsukawa Y; Ishida S; Funahashi Y; Fujita T; Kato M; Gotoh M
Aktuelle Urol; 2021 Feb; 52(1):50-53. PubMed ID: 32854127
[TBL] [Abstract] [Full Text] [Related]
9. Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer.
Yu M; Yang C; Wang S; Zeng Y; Chen Z; Feng N; Ning C; Wang L; Xue L; Zhang Z
Clin Chim Acta; 2020 Nov; 510():437-441. PubMed ID: 32791134
[TBL] [Abstract] [Full Text] [Related]
10. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
[TBL] [Abstract] [Full Text] [Related]
11. Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis.
Jiang H; Guo S; Zhao Y; Wang Y; Piao HY; Wu Y; Zhang J
Pathol Res Pract; 2019 Oct; 215(10):152569. PubMed ID: 31421977
[TBL] [Abstract] [Full Text] [Related]
12. A 5-year follow-up of primary seminal vesicle adenocarcinoma: A case report.
Yin T; Jiang Y
Medicine (Baltimore); 2018 Oct; 97(41):e12600. PubMed ID: 30313047
[TBL] [Abstract] [Full Text] [Related]
13. [Clinicopathological features of primary seminal vesicle adenocarcinoma: A report of 4 cases and review of the literature].
Guo JN; Li H; Hu ZD; Liang EL; Chang JW
Zhonghua Nan Ke Xue; 2017 Jul; 23(7):639-645. PubMed ID: 29723459
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival.
Temkin SM; Miller EA; Samimi G; Berg CD; Pinsky P; Minasian L
Eur J Cancer; 2017 Dec; 87():182-188. PubMed ID: 29156299
[TBL] [Abstract] [Full Text] [Related]
15. Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents.
Higgins V; Fung AWS; Chan MK; Macri J; Adeli K
Clin Chem Lab Med; 2018 Jan; 56(2):327-340. PubMed ID: 28723610
[TBL] [Abstract] [Full Text] [Related]
16. Primary adenocarcinoma of the seminal vesicles. A review of the literature.
Katafigiotis I; Sfoungaristos S; Duvdevani M; Mitsos P; Roumelioti E; Stravodimos K; Anastasiou I; Constantinides CA
Arch Ital Urol Androl; 2016 Mar; 88(1):47-51. PubMed ID: 27072175
[TBL] [Abstract] [Full Text] [Related]
17. Variant prostate carcinoma and elevated serum ca-125.
Bilen MA; Reyes A; Bhowmick D; Maa A; Bast R; Pisters LL; Lin SH; Logothetis CJ; Tu SM
Can J Urol; 2014 Oct; 21(5):7442-8. PubMed ID: 25347368
[TBL] [Abstract] [Full Text] [Related]
18. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
[TBL] [Abstract] [Full Text] [Related]
19. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.
Nolen BM; Brand RE; Prosser D; Velikokhatnaya L; Allen PJ; Zeh HJ; Grizzle WE; Huang Y; Lomakin A; Lokshin AE
PLoS One; 2014; 9(4):e94928. PubMed ID: 24747429
[TBL] [Abstract] [Full Text] [Related]
20. [A case of primary seminal vesicle cancer detected by FDG-PET/CT].
Mizuno N; Fujikawa N; Hayashi N; Murakami T; Suzuki K; Ikeda I
Nihon Hinyokika Gakkai Zasshi; 2012 Nov; 103(6):704-7. PubMed ID: 24261194
[TBL] [Abstract] [Full Text] [Related]
[Next]
